Boehringer Offers EU Concessions For Sanofi Swap Deal
German Pharmaceutical company Boehringer Ingelheim has reportedly offered concessions to the European Commission to alleviate competition concerns over the proposed swap of its consumer health care business for French pharmaceutical company...To view the full article, register now.
Already a subscriber? Click here to view full article